ORKA EBITDA Growth
Oruka Therapeutics Inc · EBITDA Growth
ORKA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-27.50%period ending
ORKA TTM EBITDA YoY % (57.13% → -27.50%)
Year-over-year change
High-resolution chart · PNG
ORKA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -27.5034% | |
| -6.7761% | |
| -27.025% | |
| -143.1928% | |
| -460.0517% | |
| -11,634.83% | |
| -1,486.3896% | |
| -777.3695% | |
| -219.0254% | |
| 111.9594% | |
| 46.7183% | |
| 62.927% | |
| 62.7553% | |
| 57.1281% | |
| 48.9782% | |
| 23.4164% | |
| -4.5398% | |
| -47.8813% | |
| -99.3883% | |
| -224.8523% | |
| -221.5868% | |
| -142.8153% | |
| -73.5961% | |
| 1.168% | |
| 20.7342% | |
| 26.1747% | |
| 30.0428% | |
| 45.6396% | |
| 53.6544% | |
| 59.0001% | |
| 57.1259% |